Hints and tips:
...The group this year sold its stake in vaccines maker Medicago amid suggestions that its involvement was holding back the company’s progress. The business of corporate transformation can’t be rushed....
...Yet technology firms and other sought-after tenants are paying a premium for space at One Vanderbilt, an SL Green-owned tower by Grand Central Terminal that is one of the city’s newest offerings....
...Given its success in London, Stocked will travel to other cities in the UK, with a possible Christmas event in Manchester, and then Bristol in the new year....
...It exited its position in generic drugs maker Teva and sold more than 70 per cent of its remaining shares in AbbVie and Bristol-Myers Squibb....
...The carmaker limits the size of loans senior leaders can take out by pledging their shares to 25 per cent of the value of an executive’s holdings....
...Berkshire reduced its stakes in drugmakers including Merck, Bristol-Myers Squibb and AbbVie in the first quarter, cut more than half of its holding in oil major Chevron, and sold the entirety of its positions...
...It increased its stakes in AbbVie, Bristol-Myers Squibb and Merck, but sold out of Pfizer....
...Warren Buffett’s Berkshire Hathaway placed a $5.7bn bet on four US pharmaceutical stocks in the third quarter, as the billionaire investor dumped holdings in several of the largest US banks....
...The size of these holdings, and how much each party paid for them, remain a mystery (get in touch with us if you have details)....
...Filings with the Securities and Exchange Commission show Renaissance owned almost 4m Tesla shares at the end of last year, making the Elon Musk company its second-largest holding behind Bristol-Myers Squibb...
...The dismal conditions at the care home in Bristol, south-west England, found in January last year, were a sign of the financial pressures on its manager Four Seasons, Britain’s second-largest care home provider...
...The deal for a holding in one of the UK’s largest independent producers comes as streaming services battle to win subscribers through more original content....
...Few of the children at Ashton Gate Primary in Bristol will know that their school was once the headquarters of a global tobacco company....
...Yet with several failed merger attempts in the past five years, shareholders aren’t holding their breath....
...Merck and Bristol-Myers Squibb dominated the first wave of treatments. Roche, Pfizer and AstraZeneca are among those hoping to catch up fast....
...More than 15 imported drugs have been approved this year, including Bristol-Myers Squibb’s Opdivo in June, Merck’s Keytruda last month and Roche’s Alecensa this month, all part of a generation of immunotherapy...
...CreditSights looked at some of the biggest potential deals — Bristol-Myers Squibb/Gilead, Qualcomm/Broadcom, something involving Kraft Heinz — and added them up....
...Another earnings-driven move on Thursday came from pharmaceutical group Bristol-Myers Squibb, which fell 4.8 per cent to $60.95 after it narrowly missed Wall Street forecasts for third-quarter earnings....
...“Medivation was not a good deal and it has made people really scared,” says one investor with large holdings of Pfizer and Gilead....
...Credit default swaps that are used by investors to hedge holdings of the company’s bonds were the worst performers on Tuesday in an index compiled by Markit that tracks such derivatives on investment-grade...
...Bristol plans a £600m deep-sea terminal and Dover is spending £250m on its western docks to improve freight facilities....
...Shares in Bristol-Myers Squibb plummeted by 17 per cent in premarket trading, after its novel cancer drug failed in a late-stage clinical trial....
...Healthcare stocks in the US slid on Monday in a lacklustre trading session as investors digested disappointing results from Allergan, days after a potential blockbuster cancer treatment from Bristol-Myers...
...Indofood of Indonesia is famed for its instant noodles, while Turkey’s Yildiz Holding owns McVitie’s biscuits, Godiva chocolates and Jacob’s crackers....
...That has begun to change since the arrival of Keytruda, the drug by Merck of the US given to Mr Carter, and a rival product, Bristol-Myers Squibb’s Opdivo....
International Edition